The Business Research Company's Blood Based Biomarkers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
What Is The Anticipated Growth Of The Blood-Based Biomarkers Market?
The market growth is only predicted to pick up more momentum in the years to come, with projections indicating a growth to $41.55 billion in 2029 at a CAGR of 12.4%. The rise in the forecast period can be attributed largely to the expansion of artificial intelligence AI and machine learning in biomarker analysis, an increased demand for early disease detection, advances in telemedicine and remote diagnostics, the rising prevalence of chronic diseases, and greater consumer health awareness. The trends to make a significant impact on the forecast period include AI-driven biomarker discovery, advancements in liquid biopsy, the integration of multi-omics, and innovations in point-of-care POC testing devices and next-generation sequencing NGS.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24176&type=smp
What Is Driving The Growth In The Blood-Based Biomarkers Market?
One of the key growth catalysts of the blood-based biomarkers market is the escalating cases of cardiovascular diseases. These refer to a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, and stroke. The rise in cardiovascular diseases is attributed largely to increased risk factors such as poor diet and rising obesity rates. Blood-based biomarkers play a critical role in diagnosing and monitoring cardiovascular diseases as they provide informative insights into disease progression, risk assessment, and treatment response through measurable substances in the blood. For instance, in September 2024, according to the National Center for Biotechnology Information, a US-based government agency reported a global health research initiative. The findings indicated a future 90% surge in cardiovascular disease prevalence between 2025 and 2050, with anticipated cardiovascular deaths reaching a staggering 35.6 million by 2050. This surge in cardiovascular diseases has and will continue to propel the growth of blood-based biomarkers.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/blood-based-biomarkers-global-market-report
Who Are The Keen Competitors In The Blood-Based Biomarkers Market
The blood-based biomarkers market field is dominated by key industry players including Siemens Healthineers AG, Agilent Technologies Inc, Eisai Co Ltd, Sysmex Corporation, Exact Sciences Corporation, Guardant Health, Quanterix Corporation, Illumina Inc, QIAGEN NV, GENFIT, Foundation Medicine Inc, Adaptive Biotechnologies Corporation, GRAIL LLC, Biodesix Inc, Cleveland Diagnostics Inc, Creative Diagnostics, Epigenomics AG, C2N Diagnostics, Diadem srl, and Proteomedix AG. The competitive landscape is replete with technological advancements such as high-accuracy blood biomarker tests to aid physician diagnosis of Alzheimer’s disease and the market's continued growth.
How Is The Blood-Based Biomarkers Market Segmented?
The blood-based biomarkers market, as covered in this report, is segmented –
1 By Type: Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Cell-Based Biomarkers, Epigenetic Biomarkers
2 By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Immunoassays, Mass Spectrometry, Other Technologies
3 By Application: Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other Applications
4 By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End Users.
What Regional Insights Impact The Blood-Based Biomarkers Market Logistics?
In 2024, North America reigned as the largest regional market for blood-based biomarkers market. However, by the forecast period, Asia-Pacific is predicted to be the fastest-growing region. The blood-based biomarkers regional market spans across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Cancer Biomarker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report
Renal Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Biomarkers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
About The Business Research Company:
With a portfolio of over 15000+ reports across 27 industries and 60+ geographies, The Business Research Company has built a commendable reputation for offering comprehensive, data-rich research and insights. Leveraging 1,500,000 datasets, in-depth secondary research, and unique insights from industry leaders, you can obtain the information you need to outshine the competition.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info